Sharma, Akshay http://orcid.org/0000-0003-3281-2081
Huang, Sujuan
Li, Ying
Brooke, Russell J. http://orcid.org/0000-0001-7115-2990
Ahmed, Ibrahim http://orcid.org/0000-0001-5525-9798
Allewelt, Heather B.
Amrolia, Persis http://orcid.org/0000-0003-0480-3911
Bertaina, Alice http://orcid.org/0000-0002-3729-436X
Bhatt, Neel S. http://orcid.org/0000-0003-2033-1125
Bierings, Marc B. http://orcid.org/0000-0002-0192-3080
Bies, Joshua
Brisset, Claire
Brondon, Jennifer E.
Dahlberg, Ann
Dalle, Jean-Hugues http://orcid.org/0000-0002-8406-0793
Eissa, Hesham
Fahd, Mony
Gassas, Adam
Gloude, Nicholas J.
Goebel, W. Scott
Goeckerman, Erika S.
Harris, Katherine
Ho, Richard
Hudspeth, Michelle P.
Huo, Jeffrey S. http://orcid.org/0000-0002-0057-9118
Jacobsohn, David http://orcid.org/0000-0001-6119-3270
Kasow, Kimberly A.
Katsanis, Emmanuel http://orcid.org/0000-0003-1466-6965
Kaviany, Saara
Keating, Amy K.
Kernan, Nancy A.
Ktena, Yiouli P.
Lauhan, Colette R.
López-Hernandez, Gerardo http://orcid.org/0000-0002-2586-9031
Martin, Paul L.
Myers, Kasiani C. http://orcid.org/0000-0002-5528-4405
Naik, Swati
Olaya-Vargas, Alberto
Onishi, Toshihiro http://orcid.org/0000-0002-0722-9233
Radhi, Mohamed
Ramachandran, Shanti
Ramos, Kristie
Rangarajan, Hemalatha G. http://orcid.org/0000-0003-3371-2920
Roehrs, Philip A.
Sampson, Megan E.
Shaw, Peter J. http://orcid.org/0000-0003-0101-4482
Skiles, Jodi L.
Somers, Katherine
Symons, Heather J.
de Tersant, Marie
Uber, Allison N.
Versluys, Birgitta http://orcid.org/0000-0002-4283-5503
Cheng, Cheng
Triplett, Brandon M. http://orcid.org/0000-0001-8220-9980
Article History
Received: 19 May 2021
Revised: 6 August 2021
Accepted: 20 August 2021
First Online: 3 September 2021
Competing interests
: AS’s institution receives support for the conduct of industry sponsored trials from Vertex Pharmaceuticals, CRISPR Therapeutics and Novartis. AS has received consulting fee from Spotlight Therapeutics and Medexus Inc, and honoraria from Vindico Medical Education. HBA reports that she is an employee of BeiGene Ltd and began her employment after the contribution of any clinical data. RJB reports that he currently is an employee of Smith & Nephew, a position that he transitioned to while this project was ongoing. J-HD reports receiving honoraria from blue bird bio, Orchard, Jazz Pharmaceuticals, Novartis, Sanofi Genzyme and Gilead. MPH serves on the advisory board for Mesoblast. NAK has equity interest in Amgen, Johnson and Johnson, Merck and Pfizer and has received financial support for research from Jazz Pharmaceuticals. HJS reports receiving honoraria from Jazz Pharmaceuticals and has a patent US-2020-0163997-A1 with royalties paid. BMT has received financial support for research and travel from Miltenyi Biotec. Remaining authors do not have any conflicts of interest to disclose.